{"id":10331,"date":"2021-04-14T14:40:45","date_gmt":"2021-04-14T13:40:45","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=10331"},"modified":"2021-05-20T10:27:03","modified_gmt":"2021-05-20T09:27:03","slug":"conclusions-du-projet-eu-jamrai-joint-action-antimicrobial-resistance-and-healthcare-associated-infections","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conclusions-du-projet-eu-jamrai-joint-action-antimicrobial-resistance-and-healthcare-associated-infections\/","title":{"rendered":"Conclusions du projet EU-JAMRAI (Joint Action Antimicrobial Resistance and Healthcare-Associated Infections)"},"content":{"rendered":"\n<p>Le<strong>&nbsp;<a href=\"https:\/\/eu-jamrai.eu\/\" target=\"_blank\" rel=\"noreferrer noopener\">projet EU-JAMRAI<\/a><\/strong>&nbsp;(Joint Action Antimicrobial Resistance and Healthcare-Associated Infections) coordonn\u00e9e au nom de l\u2019INSERM par le Professeur Marie-C\u00e9cile PLOY (CHU de Limoges et Inserm U1092) avec le soutien du MSS s\u2019est achev\u00e9 en f\u00e9vrier 2021.<\/p>\n\n\n\n<p><strong>Les 8 notes d\u2019orientation<\/strong> \u00e9num\u00e9rant des recommandations qui concoureront \u00e0 faire de l\u2019Europe une r\u00e9gion de bonnes pratiques en mati\u00e8re de r\u00e9duction de la r\u00e9sistance aux antimicrobiens et des infections associ\u00e9es aux soins viennent d\u2019\u00eatre publi\u00e9es par EU-JAMRAI&nbsp;.<\/p>\n\n\n\n<ul><li><a href=\"https:\/\/eu-jamrai.eu\/wp-content\/uploads\/2021\/03\/201116_EUJAMRAI_policy-brief_WP4_OHN.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">The need for a reinforced AMR One Health Network<\/a>&nbsp;\u2013&nbsp;<a href=\"https:\/\/eu-jamrai.eu\/wp-content\/uploads\/2021\/03\/201116_EUJAMRAI_policy-brief_WP4_OHN_French.pdf\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Fr<\/strong><\/a><\/li><li><a href=\"https:\/\/eu-jamrai.eu\/wp-content\/uploads\/2021\/03\/201022_EUJAMRAI_policy-brief_WP4_core-elements.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">The need to develop core elements at the European level on AMS and IPC<\/a>&nbsp;\u2013&nbsp;<a href=\"https:\/\/eu-jamrai.eu\/wp-content\/uploads\/2021\/03\/201022_EUJAMRAI_policy-brief_WP4_core-elements_French.pdf\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Fr<\/strong><\/a><\/li><li><a href=\"https:\/\/eu-jamrai.eu\/wp-content\/uploads\/2021\/03\/201022_EUJAMRAI_policy-brief_WP4_indicators.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">The need to develop indicators and targets for AMR Action Plans in the EU<\/a>&nbsp;\u2013&nbsp;<strong><a href=\"https:\/\/eu-jamrai.eu\/wp-content\/uploads\/2021\/03\/201022_EUJAMRAI_policy-brief_WP4_indicators_French.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Fr<\/a><\/strong><\/li><li><a href=\"https:\/\/eu-jamrai.eu\/wp-content\/uploads\/2021\/02\/201020_EUJAMRAI_policy-brief_WP7_appropriate-use-of-antibiotics-one-health-perspective.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Appropriate use of antibiotics in a One Health perspective<\/a>&nbsp;\u2013&nbsp;<a href=\"https:\/\/eu-jamrai.eu\/wp-content\/uploads\/2021\/03\/201020_EUJAMRAI_policy-brief_WP7_appropriate-use-of-antibiotics-one-health-perspective_French.pdf\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Fr<\/strong><\/a><\/li><li><a href=\"https:\/\/eu-jamrai.eu\/wp-content\/uploads\/2021\/02\/201116_EUJAMRAI_policy-brief_WP7_EARS-Vet.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">European Antimicrobial Resistance Surveillance network in Veterinary medicine (EARS-Vet)<\/a>&nbsp;\u2013&nbsp;<a href=\"https:\/\/eu-jamrai.eu\/wp-content\/uploads\/2021\/03\/201116_EUJAMRAI_policy-brief_WP7_EARS-Vet_French.pdf\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Fr<\/strong><\/a><\/li><li><a href=\"https:\/\/eu-jamrai.eu\/wp-content\/uploads\/2021\/02\/201207_EUJAMRAI_policy-brief_WP9_research-on-IPC.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">The urgent need to foster research on Infection Prevention and Control to improve health security<\/a>&nbsp;\u2013&nbsp;<a href=\"https:\/\/eu-jamrai.eu\/wp-content\/uploads\/2021\/03\/201207_EUJAMRAI_policy-brief_WP9_research-on-IPC_French.pdf\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Fr<\/strong><\/a><\/li><li><a href=\"https:\/\/eu-jamrai.eu\/wp-content\/uploads\/2021\/02\/201211_EUjamrai_policy-brief_WP9_hub-incentives.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Incentivizing antibiotic access and innovation<\/a>&nbsp;\u2013<strong>&nbsp;<a href=\"https:\/\/eu-jamrai.eu\/wp-content\/uploads\/2021\/03\/201211_EUjamrai_policy-brief_WP9_hub-incentives_French.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Fr<\/a><\/strong><\/li><li><a href=\"https:\/\/eu-jamrai.eu\/wp-content\/uploads\/2021\/03\/210315_EUjamrai_policy-brief_WP9_evidence-in-policy-making.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Understanding the use of evidence in health policymaking<\/a><\/li><\/ul>\n\n\n\n<p>Note&nbsp;: Le symbole Fr renvoie vers la version en fran\u00e7ais quand elle existe.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le&nbsp;projet EU-JAMRAI&nbsp;(Joint Action Antimicrobial Resistance and Healthcare-Associated Infections) coordonn\u00e9e au nom de l\u2019INSERM par le Professeur Marie-C\u00e9cile PLOY (CHU de Limoges et Inserm U1092) avec le soutien du MSS s\u2019est achev\u00e9 en f\u00e9vrier 2021. Les 8 notes d\u2019orientation \u00e9num\u00e9rant des recommandations qui concoureront \u00e0 faire de l\u2019Europe une r\u00e9gion de bonnes pratiques en mati\u00e8re de [&hellip;]<\/p>\n","protected":false},"author":139,"featured_media":10339,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[31,37],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Conclusions du projet EU-JAMRAI (Joint Action Antimicrobial Resistance and Healthcare-Associated Infections) - Interface nationale ANTIBIOR\u00c9SISTANCE<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conclusions-du-projet-eu-jamrai-joint-action-antimicrobial-resistance-and-healthcare-associated-infections\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Conclusions du projet EU-JAMRAI (Joint Action Antimicrobial Resistance and Healthcare-Associated Infections) - Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conclusions-du-projet-eu-jamrai-joint-action-antimicrobial-resistance-and-healthcare-associated-infections\/\" \/>\n<meta property=\"og:site_name\" content=\"Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-14T13:40:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-05-20T09:27:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/04\/Ampoule.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"608\" \/>\n\t<meta property=\"og:image:height\" content=\"592\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"\u00c9milie Noguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u00c9milie Noguez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conclusions-du-projet-eu-jamrai-joint-action-antimicrobial-resistance-and-healthcare-associated-infections\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conclusions-du-projet-eu-jamrai-joint-action-antimicrobial-resistance-and-healthcare-associated-infections\/\"},\"author\":{\"name\":\"\u00c9milie Noguez\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\"},\"headline\":\"Conclusions du projet EU-JAMRAI (Joint Action Antimicrobial Resistance and Healthcare-Associated Infections)\",\"datePublished\":\"2021-04-14T13:40:45+00:00\",\"dateModified\":\"2021-05-20T09:27:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conclusions-du-projet-eu-jamrai-joint-action-antimicrobial-resistance-and-healthcare-associated-infections\/\"},\"wordCount\":219,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conclusions-du-projet-eu-jamrai-joint-action-antimicrobial-resistance-and-healthcare-associated-infections\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/04\/Ampoule.jpg\",\"articleSection\":[\"Actualit\u00e9s\",\"Bilans, rapports et recommandations\"],\"inLanguage\":\"fr-FR\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conclusions-du-projet-eu-jamrai-joint-action-antimicrobial-resistance-and-healthcare-associated-infections\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conclusions-du-projet-eu-jamrai-joint-action-antimicrobial-resistance-and-healthcare-associated-infections\/\",\"name\":\"Conclusions du projet EU-JAMRAI (Joint Action Antimicrobial Resistance and Healthcare-Associated Infections) - Interface nationale ANTIBIOR\u00c9SISTANCE\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conclusions-du-projet-eu-jamrai-joint-action-antimicrobial-resistance-and-healthcare-associated-infections\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conclusions-du-projet-eu-jamrai-joint-action-antimicrobial-resistance-and-healthcare-associated-infections\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/04\/Ampoule.jpg\",\"datePublished\":\"2021-04-14T13:40:45+00:00\",\"dateModified\":\"2021-05-20T09:27:03+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conclusions-du-projet-eu-jamrai-joint-action-antimicrobial-resistance-and-healthcare-associated-infections\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conclusions-du-projet-eu-jamrai-joint-action-antimicrobial-resistance-and-healthcare-associated-infections\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conclusions-du-projet-eu-jamrai-joint-action-antimicrobial-resistance-and-healthcare-associated-infections\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/04\/Ampoule.jpg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/04\/Ampoule.jpg\",\"width\":608,\"height\":592,\"caption\":\"Cr\u00e9dit : Pixabay\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conclusions-du-projet-eu-jamrai-joint-action-antimicrobial-resistance-and-healthcare-associated-infections\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Infos pratiques &amp; communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Actualit\u00e9s\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Conclusions du projet EU-JAMRAI (Joint Action Antimicrobial Resistance and Healthcare-Associated Infections)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"name\":\"Interface nationale ANTIBIOR\u00c9SISTANCE\",\"description\":\"PPR Antibior\u00e9sistance - Inserm\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\",\"name\":\"\u00c9milie Noguez\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Conclusions du projet EU-JAMRAI (Joint Action Antimicrobial Resistance and Healthcare-Associated Infections) - Interface nationale ANTIBIOR\u00c9SISTANCE","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conclusions-du-projet-eu-jamrai-joint-action-antimicrobial-resistance-and-healthcare-associated-infections\/","og_locale":"fr_FR","og_type":"article","og_title":"Conclusions du projet EU-JAMRAI (Joint Action Antimicrobial Resistance and Healthcare-Associated Infections) - Interface nationale ANTIBIOR\u00c9SISTANCE","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conclusions-du-projet-eu-jamrai-joint-action-antimicrobial-resistance-and-healthcare-associated-infections\/","og_site_name":"Interface nationale ANTIBIOR\u00c9SISTANCE","article_published_time":"2021-04-14T13:40:45+00:00","article_modified_time":"2021-05-20T09:27:03+00:00","og_image":[{"width":608,"height":592,"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/04\/Ampoule.jpg","type":"image\/jpeg"}],"author":"\u00c9milie Noguez","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"\u00c9milie Noguez","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conclusions-du-projet-eu-jamrai-joint-action-antimicrobial-resistance-and-healthcare-associated-infections\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conclusions-du-projet-eu-jamrai-joint-action-antimicrobial-resistance-and-healthcare-associated-infections\/"},"author":{"name":"\u00c9milie Noguez","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3"},"headline":"Conclusions du projet EU-JAMRAI (Joint Action Antimicrobial Resistance and Healthcare-Associated Infections)","datePublished":"2021-04-14T13:40:45+00:00","dateModified":"2021-05-20T09:27:03+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conclusions-du-projet-eu-jamrai-joint-action-antimicrobial-resistance-and-healthcare-associated-infections\/"},"wordCount":219,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conclusions-du-projet-eu-jamrai-joint-action-antimicrobial-resistance-and-healthcare-associated-infections\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/04\/Ampoule.jpg","articleSection":["Actualit\u00e9s","Bilans, rapports et recommandations"],"inLanguage":"fr-FR"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conclusions-du-projet-eu-jamrai-joint-action-antimicrobial-resistance-and-healthcare-associated-infections\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conclusions-du-projet-eu-jamrai-joint-action-antimicrobial-resistance-and-healthcare-associated-infections\/","name":"Conclusions du projet EU-JAMRAI (Joint Action Antimicrobial Resistance and Healthcare-Associated Infections) - Interface nationale ANTIBIOR\u00c9SISTANCE","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conclusions-du-projet-eu-jamrai-joint-action-antimicrobial-resistance-and-healthcare-associated-infections\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conclusions-du-projet-eu-jamrai-joint-action-antimicrobial-resistance-and-healthcare-associated-infections\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/04\/Ampoule.jpg","datePublished":"2021-04-14T13:40:45+00:00","dateModified":"2021-05-20T09:27:03+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conclusions-du-projet-eu-jamrai-joint-action-antimicrobial-resistance-and-healthcare-associated-infections\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conclusions-du-projet-eu-jamrai-joint-action-antimicrobial-resistance-and-healthcare-associated-infections\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conclusions-du-projet-eu-jamrai-joint-action-antimicrobial-resistance-and-healthcare-associated-infections\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/04\/Ampoule.jpg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/04\/Ampoule.jpg","width":608,"height":592,"caption":"Cr\u00e9dit : Pixabay"},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conclusions-du-projet-eu-jamrai-joint-action-antimicrobial-resistance-and-healthcare-associated-infections\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/"},{"@type":"ListItem","position":2,"name":"Infos pratiques &amp; communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/"},{"@type":"ListItem","position":3,"name":"Actualit\u00e9s","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/"},{"@type":"ListItem","position":4,"name":"Conclusions du projet EU-JAMRAI (Joint Action Antimicrobial Resistance and Healthcare-Associated Infections)"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","name":"Interface nationale ANTIBIOR\u00c9SISTANCE","description":"PPR Antibior\u00e9sistance - Inserm","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3","name":"\u00c9milie Noguez"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-23 06:06:04","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/10331"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/users\/139"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/comments?post=10331"}],"version-history":[{"count":22,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/10331\/revisions"}],"predecessor-version":[{"id":10377,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/10331\/revisions\/10377"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media\/10339"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media?parent=10331"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/categories?post=10331"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/tags?post=10331"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}